TASK THERAPEUTICS Trademark
Trademark Overview
On Wednesday, September 16, 2020, a trademark application was filed for TASK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TASK THERAPEUTICS trademark a serial number of 90185610. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 18, 2021. This trademark is owned by ZIOPHARM Oncology, Inc. The TASK THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceuticals for the treatment of cancer; biochemical and biopharmaceutical preparations for the treatment of cancer; gene therapy products, namely, genetically engineered materials for the treatment of cancer; cells for medical or clinical use; preparations for genetically modifying human and animal cells for diagnostic and medical purposes; preparations of blood or cells extracted from humans or animals which have been adapted for therapeutic purposes
Medical research
Cell therapy services; gene therapy services
General Information
Serial Number | 90185610 |
Word Mark | TASK THERAPEUTICS |
Filing Date | Wednesday, September 16, 2020 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, August 18, 2021 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Pharmaceuticals for the treatment of cancer; biochemical and biopharmaceutical preparations for the treatment of cancer; gene therapy products, namely, genetically engineered materials for the treatment of cancer; cells for medical or clinical use; preparations for genetically modifying human and animal cells for diagnostic and medical purposes; preparations of blood or cells extracted from humans or animals which have been adapted for therapeutic purposes |
Goods and Services | Medical research |
Goods and Services | Cell therapy services; gene therapy services |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 23, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 23, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, September 22, 2020 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | ZIOPHARM Oncology, Inc |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Boston, MA 02129 |
Trademark Events
Event Date | Event Description |
Wednesday, August 18, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Wednesday, August 18, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, February 3, 2021 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
Wednesday, February 3, 2021 | PRIORITY ACTION E-MAILED |
Wednesday, February 3, 2021 | PRIORITY ACTION WRITTEN |
Thursday, January 28, 2021 | ASSIGNED TO EXAMINER |
Friday, October 23, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Monday, September 21, 2020 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Monday, September 21, 2020 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Saturday, September 19, 2020 | NEW APPLICATION ENTERED IN TRAM |